Bethanechol’s muscarinic agonist activity can trigger predictable cholinergic effects; proactive monitoring prevents complications.
Mild gastrointestinal cramps, nausea, and sweating are common. Serious but uncommon reactions include bronchospasm, bradycardia, or hypotension, especially in children with asthma or cardiac disease.
2 documented effects
Not specified
Reduce dose or divide dosing as directed; ensure adequate hydration.
Monitor for symptom escalation or new adverse effects.
Not specified
Administer with a light snack if approved, and notify the clinician if symptoms persist.
Monitor for symptom escalation or new adverse effects.
1 documented effect
Not specified
Emergency care; discontinue therapy.
Monitor for symptom escalation or new adverse effects.
1 documented effect
Not specified
Stop drug and seek urgent evaluation; atropine may be required in clinical settings.
Monitor for symptom escalation or new adverse effects.
1 documented effect
Not specified
Monitor symptoms; check blood pressure and adjust dose if associated with hypotension.
Monitor for symptom escalation or new adverse effects.
For babies taking Bethanechol, watch for signs of side effects. This medication is generally well-tolerated in infants when used as directed.
If your toddler is taking Bethanechol, they might feel different. This is usually temporary and normal.
Tell us if your tummy hurts or it is hard to breathe after your medicine.
Watch for dizziness, sweating, or trouble breathing and call right away.
A: May be a sign of too high a dose; contact care team.
When to validate: Seek care if diarrhea causes dehydration.
A: Discuss timing adjustments with the clinician.
When to validate: Call if urinary leakage worsens.
Clinical assessment framework for Bethanechol adverse effects using standardized severity grading.
Parent and clinician concerns about Bethanechol